Novo Nordisk announced that Canadians with diabetes will soon have access to a once-weekly insulin injection, Awiqli, starting June 30. This marks the world’s first basal insulin injection that only needs to be taken weekly. Approved by Health Canada in March, Awiqli will benefit both Type 1 and Type 2 diabetes patients, though it is … Continue reading Canada Introduces Once-Weekly Insulin for Diabetics